Responses
Abstracts accepted for publication
Rheumatoid arthritis - other biologic treatment
AB0308 Optimal timing for tocilizumab administration to patients with rheumatoid arthritis in japan based on a cost-effectiveness analysis using the iorra cohort study
Compose a Response to This Article
Other responses
No responses have been published for this article.